Perspective Therapeutics (STU:AAJ0) SpecialCharges

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:AAJ0 Perspective Therapeutics Inc STU:AAJ0
35 GF Score
Price €2.73
GF Value €0.68
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Perspective Therapeutics SpecialCharges?

Special Charges only applies to banks.

STU:AAJ0
35GF Score
Perspective Therapeutics Inc STU:AAJ0
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Perspective Therapeutics (STU:AAJ0) Overvalued in 2026?

Based on GuruFocus' analysis, Perspective Therapeutics stock appears to be overvalued. The current stock price of €2.73 is trading 301.8% above its estimated GF Value™ of €0.68. GuruFocus considers Perspective Therapeutics to be Significantly Overvalued.

Key valuation signals for STU:AAJ0:

  • SpecialCharges:
  • GF Value™: €0.68 vs. price of €2.73 (301.8% above fair value)
  • GF Score™: 35/100 with 1 warning sign

No single metric tells the full story. See the STU:AAJ0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Perspective Therapeutics Business Description

Other Exchanges CATX:USAAAJ0:Germany
Address 2401 Elliott Avenue, Suite 320, Seattle, WA, USA, 98121
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
35GF Score

Get the complete analysis for STU:AAJ0

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.73
Price
€0.68
GF Value